Global Pulse Oximetry Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Product;

Bedside/Desktop Pulse Oximeters, Handheld Pulse Oximeters, Fingertip Pulse Oximeters, and Wrist-Worn Pulse Oximeters

By Technology;

Conventional and Smart

By End-User;

Hospitals and Ambulatory Surgical Centers, Clinics, Home Healthcare, and Others

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn133750290 Published Date: May, 2025 Updated Date: June, 2025

Pulse Oximetry Market Overview

Pulse Oximetry Market (USD Million)

Pulse Oximetry Market was valued at USD 2,794.61 million in the year 2024. The size of this market is expected to increase to USD 4,477.27 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 7.0%.


Global Pulse Oximetry Market Growth, Share, Size, Trends and Forecast

*Market size in USD million

CAGR 7.0 %


Study Period2025 - 2031
Base Year2024
CAGR (%)7.0 %
Market Size (2024)USD 2,794.61 Million
Market Size (2031)USD 4,477.27 Million
Market ConcentrationMedium
Report Pages332
2,794.61
2024
4,477.27
2031

Major Players

  • Masimo Corporation
  • Medtronic plc (formerly Covidien)
  • Koninklijke Philips N.V.
  • GE Healthcare
  • Smiths Medical (a division of Smiths Group plc)
  • Nonin Medical, Inc.
  • Nihon Kohden Corporation
  • Contec Medical Systems Co., Ltd.
  • Mindray Medical International Limited
  • Spacelabs Healthcare

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Global Pulse Oximetry Market

Fragmented - Highly competitive market without dominant players


The pulse oximetry market is experiencing notable growth due to the rising preference for non-invasive diagnostic tools across clinical and homecare environments. These devices deliver immediate readings of oxygen saturation (SpO2) and heart rate, making them indispensable in respiratory and cardiovascular care. An estimated 55% of emergency and outpatient settings now utilize pulse oximeters as part of routine examinations, highlighting their expanding clinical relevance.

Impact of Chronic Health Conditions
The increasing burden of chronic respiratory and cardiovascular disorders is a major factor fueling the market. Conditions such as asthma, heart disease, and COPD demand continuous oxygen level monitoring to ensure effective management. Current healthcare protocols indicate that over 60% of long-term treatment plans now incorporate pulse oximetry, reinforcing its value in ongoing patient care and early detection strategies.

Technological Innovations Driving Market Evolution
Advancements in pulse oximeter technology—such as enhanced motion tolerance, wireless syncing, and mobile integration—are transforming user experience and clinical workflows. These improvements are particularly beneficial for remote monitoring and telehealth applications. Approximately 48% of recently launched pulse oximeters now include smartphone connectivity, enabling users to track health data with greater ease and precision.

Policy Support and Focus on Preventive Health
Governmental and institutional backing is further supporting the market through reimbursement policies and healthcare guidelines. With a strong emphasis on preventive care, pulse oximeters are increasingly included in public health initiatives. Over 42% of chronic care programs now recommend or mandate oxygen monitoring, underscoring the technology’s essential role in proactive healthcare strategies.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By Technology
    3. Market Snapshot, By End-user
    4. Market Snapshot, By Region
  4. Pulse Oximetry Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Rising cases of respiratory and cardiac disorders

        2. Growth in critical care and monitoring demand

        3. Increased adoption in ambulatory settings

        4. Technological improvements in sensor accuracy

      2. Restraints
        1. False readings in skin tone and movement

        2. Device saturation in high-income regions

        3. Limited product awareness in rural areas

        4. Cost barriers for multi-parameter monitors

      3. Opportunities
        1. Expansion in neonatal and pediatric monitoring

        2. Integration with real-time data transmission systems

        3. Wearable pulse oximeters for personal use

        4. Research into AI-driven predictive analytics

    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Pulse Oximetry Market, By Product, 2021 - 2031 (USD Million)
      1. Bedside/desktop pulse oximeters
      2. Handheld pulse oximeters
      3. Fingertip pulse oximeters
      4. Wrist-worn pulse oximeters
    2. Pulse Oximetry Market, By Technology, 2021 - 2031 (USD Million)
      1. Conventional
      2. Smart
    3. Pulse Oximetry Market, By End-user, 2021 - 2031 (USD Million)
      1. Hospitals
      2. Ambulatory Surgical Centers
      3. Clinics
      4. Home Healthcare
      5. Others
    4. Pulse Oximetry Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Masimo Corporation
      2. Medtronic plc (formerly Covidien)
      3. Koninklijke Philips N.V.
      4. GE Healthcare
      5. Smiths Medical (a division of Smiths Group plc)
      6. Nonin Medical, Inc.
      7. Nihon Kohden Corporation
      8. Contec Medical Systems Co., Ltd.
      9. Mindray Medical International Limited
      10. Spacelabs Healthcare
  7. Analyst Views
  8. Future Outlook of the Market